Main Image

About Chronic Myelogenous Leukemia

What is Chronic Myelogenous Leukemia?

Chronic myelogenous leukemia (CML) is a type of cancer that affects the blood and bone marrow. It is caused by a genetic mutation in the bone marrow cells that leads to an overproduction of white blood cells. Symptoms of CML include fatigue, fever, night sweats, weight loss, and an enlarged spleen. Treatment for CML typically involves medications such as tyrosine kinase inhibitors, which can help slow the progression of the disease.

What are the symptoms of Chronic Myelogenous Leukemia?

The most common symptoms of Chronic Myelogenous Leukemia (CML) include:

-Weight loss
-Night sweats
-Loss of appetite
-Abdominal pain
-Bone pain
-Enlarged spleen
-Easy bruising or bleeding
-Shortness of breath
-Pale skin

What are the causes of Chronic Myelogenous Leukemia?

The exact cause of Chronic Myelogenous Leukemia (CML) is unknown. However, research suggests that it is caused by a genetic mutation in the bone marrow cells. This mutation is known as the Philadelphia chromosome, which is caused by a translocation of genetic material between chromosomes 9 and 22. This mutation leads to the production of an abnormal protein, known as BCR-ABL, which causes the uncontrolled growth of white blood cells. Other possible causes of CML include exposure to radiation, certain chemicals, and certain viruses.

What are the treatments for Chronic Myelogenous Leukemia?

The main treatments for Chronic Myelogenous Leukemia (CML) include:

1. Targeted Therapy: This type of therapy uses drugs that target specific molecules involved in the growth and spread of cancer cells. Examples of targeted therapies used to treat CML include tyrosine kinase inhibitors (TKIs) such as imatinib (Gleevec), dasatinib (Sprycel), nilotinib (Tasigna), bosutinib (Bosulif), and ponatinib (Iclusig).

2. Chemotherapy: This type of treatment uses drugs to kill cancer cells. Examples of chemotherapy drugs used to treat CML include hydroxyurea, cytarabine, and interferon-alpha.

3. Stem Cell Transplant: This type of treatment involves replacing

What are the risk factors for Chronic Myelogenous Leukemia?

1. Age: Most cases of CML occur in people over the age of 50.

2. Gender: Men are more likely to develop CML than women.

3. Exposure to radiation: Exposure to high levels of radiation, such as from radiation therapy, can increase the risk of CML.

4. Family history: Having a family member with CML increases the risk of developing the disease.

5. Certain genetic mutations: Certain genetic mutations, such as the Philadelphia chromosome, can increase the risk of CML.

Is there a cure/medications for Chronic Myelogenous Leukemia?

Yes, there are several treatments available for Chronic Myelogenous Leukemia (CML). These include targeted therapies such as tyrosine kinase inhibitors (TKIs) and interferon-alpha, as well as chemotherapy, stem cell transplantation, and radiation therapy. Your doctor will be able to discuss the best treatment option for you based on your individual situation.